Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories-Reference-Cited by-同舟云学术

Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories

Published:2021-08-18 Issue:9 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

van den Beld Maaike J. C.¹^ORCID,Murk Jean-Luc²,Kluytmans Jan³⁴,Koopmans Marion P. G.⁵,Reimerink Johan¹,van Loo Inge H. M.⁶,Wegdam-Blans Marjolijn C. A.⁷,Zaaijer Hans⁸,GeurtsvanKessel Corine⁵,Reusken Chantal¹,

Affiliation:

1. Centre for Infectious Disease Control, WHO COVID-19 Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven, the Netherlands

2. Microvida, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands

3. Amphia Ziekenhuis Breda, Microvida Laboratory for Microbiology, Breda, the Netherlands

4. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands

5. Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands

6. Department of Medical Microbiology, Maastricht UMC+ and Care and Public Health Research Institute, Maastricht University, Maastricht, the Netherlands

7. Department of Medical Microbiology, Laboratory for Pathology and Medical Microbiology (PAMM), Veldhoven, the Netherlands

8. Sanquin Blood Supply Foundation, Amsterdam, the Netherlands

Abstract

In response to the worldwide pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent antibody tests that flooded the market, a nationwide collaborative approach in the Netherlands was employed. Forty-one Dutch laboratories joined forces and shared their evaluation data to allow for the evaluation of a quantity of serological assays for SARS-CoV-2 that exceeds the capacity of each individual laboratory.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00767-21

Reference22 articles.

1. WHO. 2021. Coronavirus disease (COVID-19) pandemic 2020. WHO Geneva Switzerland. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 31 March 2021.

2. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020

3. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

4. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination

5. ASM. 2020. ASM expresses concern about coronavirus test reagent shortages. ASM Press, Washington, DC. https://asm.org/Articles/Policy/2020/March/ASM-Expresses-Concern-about-Test-Reagent-Shortages. Accessed 24 September 2020.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays;Microbiology Spectrum;2024-01-11

2. The Detection of SARS-CoV-2 Antibodies in an Exposed Human Population Is Biased by the Immunoassay Used: Implications in Serosurveillance;Pathogens;2023-11-16

3. Low prevalence of current and past SARS-CoV-2 infections among visitors and staff members of homelessness services in Amsterdam at the end of the second wave of infections in the Netherlands;PLOS ONE;2023-07-25

4. Comprehensive, Comparative Evaluation of 35 Manual SARS-CoV-2 Serological Assays;Microbiology Spectrum;2023-06-15

5. Digital and Analog Detection of SARS-CoV-2 Nucleocapsid Protein via an Upconversion-Linked Immunosorbent Assay;Analytical Chemistry;2023-02-27